Predictive Role of Blood Cell-Derived Inflammatory Markers for the Risk of Asymptomatic Cerebral Infarction in Essential Hypertension: A Population-Based Cross-Sectional Study in Central China

血液细胞来源炎症标志物对原发性高血压患者无症状性脑梗死风险的预测作用:一项基于中国中部人群的横断面研究

阅读:2

Abstract

OBJECTIVE: This study aimed to investigate the relationship between ACI and blood cell-derived inflammatory markers including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic immune inflammation index (SII) and systemic inflammation response index (SIRI) in an essential hypertensive (EH) cohort, and assess the predictive value of these inflammatory markers for ACI risk in this population. METHODS: A total of 583 EH patients were included and categorized into ACI (123 patients) and non-ACI (NACI) (460 patients) groups. Multivariate logistic regression analysis was performed to explore the relationship of PLR, NLR, SII and SIRI to ACI risk in EH population. We also used receiver operating characteristic curve analysis to assess the discriminative ability of four inflammatory markers in predicting ACI risk in EH population. RESULTS: ACI group exhibited higher levels of inflammatory markers (PLR, NLR, SII, and SIRI) compared to NACI group (P < 0.05). PLR (odds ratio (OR): 1.006, 95% confidence interval (CI): 1.001-1.011, P = 0.023), NLR (OR: 1.573, 95% CI: 1.225-2.021, P < 0.001), SII (OR: 1.002, 95% CI: 1.001-1.003, P < 0.001) and SIRI (OR: 1.851, 95% CI: 1.290-2.656, P = 0.001) were independent factors for ACI risk in EH patients. The odds ratios of the highest versus lowest quartile of PLR, NLR, SII and SIRI were 2.090 (95% CI 1.085-4.024), 3.049 (95% CI 1.509-6.161),2.464 (95% CI 1.278-4.749) and 3.372 (95% CI 1.709-6.652), respectively. PLR, NLR, SII, SIRI were characterized by area under the curve (0.586, 0.632, 0.591, 0.617) and cut-off value (125.834, 2.468, 532.011, 0.934), respectively. CONCLUSION: The findings suggested that PLR, SII, SIRI, especially NLR were of significant value biomarkers to positively predict ACI risk in EH population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。